Cargando…
Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
INTRODUCTION: Ischemic stroke patients with diabetes are at high risk for recurrent stroke and cardiovascular complications. Pioglitazone, a type of thiazolidinedione, has been shown to reduce cardiovascular complications in patients with ischemic stroke and type 2 diabetes (T2D) or insulin resistan...
Autores principales: | Yoo, Joonsang, Jeon, Jimin, Baik, Minyoul, Kim, Jinkwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163714/ https://www.ncbi.nlm.nih.gov/pubmed/37147722 http://dx.doi.org/10.1186/s12933-023-01841-4 |
Ejemplares similares
-
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study
por: Yoo, Joonsang, et al.
Publicado: (2022) -
Statin Treatment on Cardiovascular Risk After Retinal Artery Occlusion: A Historical Cohort Study
por: Yoo, Joonsang, et al.
Publicado: (2023) -
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
por: Bae, Jaehyun, et al.
Publicado: (2021) -
Impact of statin treatment on cardiovascular risk in patients with type 1 diabetes: a population-based cohort study
por: Yoo, Joonsang, et al.
Publicado: (2023) -
Impact of statin treatment on cardiovascular events in patients with retinal vein occlusion: a nested case-control study in Korea
por: Yoo, Joonsang, et al.
Publicado: (2023)